Pharmaceutical

Biodel Inc. will issue its third quarter fiscal year 2010 financial results on August 5, 2010. Following the release of the company's financial results, Biodel's senior management will host a conference call to discuss the results and provide an ...

Merck & Co., Inc. today announced financial results for the second quarter of 2010. The company reported non-GAAP earnings per share for the second quarter of $0.86, which excludes purchase accounting adjustments, merger-related expenses, ...

Covidien , a leading global provider of healthcare products, will present at the BMO Capital Markets 10th Annual Focus on Healthcare Conference in New York on Thursday, August 5, 2010. Jose Almeida, President, Medical Devices, will represent the ...

Speedus Corp. today announced that trading of shares of the Company's common stock will be transferred from The NASDAQ Stock Market to the OTCQB Marketplace beginning today, July 30, 2010. Investors will be able to easily trade the Company's stock ...

The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc. notes the finding of the Patents Court of the High Court of Justice of England and Wales in the patent litigation brought by Kinetic ...

BioScrip, Inc. announced 2010 second quarter revenue of $412.0 million, operating income of $13.5 million and net income of $3.1 million, or $0.06 per diluted share. Second quarter adjusted earnings per share was $0.07 per diluted share. Adjusted ...

Hotspur Technologies, Inc. announced today that it has received FDA clearance for the first three commercial products in its portfolio. These products are based on Hotspur's unique and groundbreaking technology that makes dialysis access ...

Today, Formatech, Inc. announced that it has selected Femta's FM101 therapeutic candidate to be enrolled in its Fillanthropy Program. Under this program, Formatech will donate the services required to aseptically fill and finish one lot of the drug ...